当前位置:首页 - 行情中心 - 科华生物(002022) - 财务分析 - 现金流量表

科华生物

(002022)

  

流通市值:29.57亿  总市值:29.58亿
流通股本:5.14亿   总股本:5.14亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金379,425,042.731,868,325,054.151,375,566,176.82873,716,596.44
  收到的税费返还5,122,909.411,837,220.82889,009.85582,838.46
  收到其他与经营活动有关的现金5,110,329.147,651,495.3432,114,681.5631,080,860.9
  经营活动现金流入小计389,658,281.241,917,813,770.311,408,569,868.23905,380,295.8
  购买商品、接受劳务支付的现金252,100,875.29976,696,203.78743,388,116.94477,104,365.73
  支付给职工以及为职工支付的现金136,710,222.56489,025,221.42384,225,815.11280,221,819.99
  支付的各项税费12,026,357.5355,470,658.543,000,398.0130,728,130.1
  支付其他与经营活动有关的现金91,183,883.63374,183,021.23262,052,519.52168,322,620.69
  经营活动现金流出小计492,021,339.011,895,375,104.931,432,666,849.58956,376,936.51
  经营活动产生的现金流量净额-102,363,057.7722,438,665.38-24,096,981.35-50,996,640.71
二、投资活动产生的现金流量:
  收回投资收到的现金60,000,000---
  取得投资收益收到的现金1,132,217.782,038,529.931,354,770.8950,951.51
  处置固定资产、无形资产和其他长期资产收回的现金净额2,034,241.248,099,734.384,954,381.534,099,439.37
  处置子公司及其他营业单位收到的现金净额463,213.281,500,0001,000,000100,000
  投资活动现金流入小计63,629,672.311,638,264.317,309,152.335,150,390.88
  购建固定资产、无形资产和其他长期资产支付的现金21,822,356.82139,293,855.3896,368,018.8365,131,594.22
  投资支付的现金2,100,00060,000,000--
  投资活动现金流出小计23,922,356.82199,293,855.3896,368,018.8365,131,594.22
  投资活动产生的现金流量净额39,707,315.48-187,655,591.07-89,058,866.5-59,981,203.34
三、筹资活动产生的现金流量:
  吸收投资收到的现金-2,250,0002,250,000-
  其中:子公司吸收少数股东投资收到的现金-2,250,0002,250,000-
  取得借款收到的现金134,496,697.9611,920,500.57378,539,640.48295,372,654.86
  收到其他与筹资活动有关的现金-37,003,419.55--
  筹资活动现金流入小计134,496,697.9651,173,920.12380,789,640.48295,372,654.86
  偿还债务支付的现金119,440,340.28403,316,268.52187,953,239.02172,555,251.82
  分配股利、利润或偿付利息支付的现金4,653,610.1765,642,516.3461,444,204.7454,741,780.08
  其中:子公司支付给少数股东的股利、利润-50,197,00050,197,00050,197,000
  支付其他与筹资活动有关的现金3,762,393.8324,934,036.6410,222,073.815,721,059.42
  筹资活动现金流出小计127,856,344.28493,892,821.5259,619,517.57233,018,091.32
  筹资活动产生的现金流量净额6,640,353.62157,281,098.62121,170,122.9162,354,563.54
四、汇率变动对现金及现金等价物的影响-1,320,334.43732,215.21-606,958.05584,918.12
五、现金及现金等价物净增加额-57,335,723.1-7,203,611.867,407,317.01-48,038,362.39
  加:期初现金及现金等价物余额853,173,646.06860,377,257.92860,377,257.92860,377,257.92
  期末现金及现金等价物余额795,837,922.96853,173,646.06867,784,574.93812,338,895.53
补充资料:
  净利润--884,793,893.44--140,116,685.34
  资产减值准备-305,448,001.29-21,392,766.4
  固定资产和投资性房地产折旧-128,017,469.4-61,815,708.79
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-128,017,469.4-61,815,708.79
  无形资产摊销-83,941,322.01-32,137,203.58
  长期待摊费用摊销-21,113,117.96-6,778,662.34
  处置固定资产、无形资产和其他长期资产的损失--3,869,704.67--2,344,755.76
  固定资产报废损失-2,839,379.44-352,271.69
  公允价值变动损失--32,174.4-19,103.55
  财务费用-21,001,224.93-5,930,458.53
  投资损失--1,686,331.97--715,257.64
  递延所得税-58,518,007.93--1,051,316.64
  其中:递延所得税资产减少-60,030,776.11--504,950.21
    递延所得税负债增加--1,512,768.18--546,366.43
  存货的减少--5,211,881.26-41,234,982.33
  经营性应收项目的减少-76,356,619.51-37,451,874.2
  经营性应付项目的增加-40,882,898.38--137,559,322.84
  一年内到期的可转换公司债券-221,497,989.83--
  现金的期末余额-853,173,646.06-812,338,895.53
  减:现金的期初余额-860,377,257.92-860,377,257.92
  现金及现金等价物的净增加额--7,203,611.86--48,038,362.39
公告日期2026-04-282026-04-172025-10-302025-08-27
审计意见(境内)标准无保留意见
TOP↑